Milvexian for the Prevention of Venous Thromboembolism | NEJM
Original Article from The New England Journal of Medicine — Milvexian for the Prevention of Venous Thromboembolism
Related Articles
Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study
AbstractBackground. The ONCO DVT study revealed the superiority of 12-month relative to 3-month edoxaban treatment for cancer-associated isolated distal de
TG CULTURA – ” SA DIE DE SA SARDIGNA”, a Parigi l’omaggio al patriota Michele Obino – 23.04.2024 – Videolina
Video Clips – Approfondisci su Videolina
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
Carriers of the E40K loss-of-function variant in Angiopoietin-like 4 (ANGPTL4), have lower plasma triglyceride levels as well as lower rates of coronary artery disease (CAD)…
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM
The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized…
Body Mass Index and All-Cause and Cardiovascular Mortality in United States Adults With and Without Atherosclerotic Cardiovascular Disease: Findings from the National Health Interview Survey | Population Health Management
In a nationally representative population-based study of US adults, the authors sought to examine the association between body mass index (BMI) and all-cause and cardiovascular…
Nobili sorelle Angioy (Le) – Libri Sardi
Benvenuti sul sito librisardi.it Chiudi Questo sito web utilizza i cookie per migliorare la tua esperienza du rante la navigazione nel sito Web. Di questi…
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries
AbstractAims. To assess use and associations with outcomes of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a real-world population with heart fa
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
AbstractAims. Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) have a direct cardiac effect that is likely to be independent of its glucose lowering re
Body mass index, waist circumference, and mortality in subjects older than 80 years: a Mendelian randomization study
AbstractBackground and Aims. Emerging evidence has raised an obesity paradox in observational studies of body mass index (BMI) and health among the oldest-
Accueil
Chères consœurs, chers confrères, Vous avez été 1 264 l’année dernière à répondre à la première enquête nationale multidisciplinaire sur la prise en charge diagnostique…